Business & Regulation

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

AI is expanding into medicine. Are the world’s regulators ready?

What strategies can pharma employ to protect itself against cyber threats?

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne.

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.

We interview Mary Lavin, President of Sartorius North America, about her career.